Omeros Corporation (OMER) Financials
OMER Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 493.1 million | 507.0 million |
2023-06-30 | 527.4 million | 506.9 million |
2023-03-31 | 560.1 million | 505.2 million |
2022-12-31 | 591.0 million | 505.3 million |
OMER Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -32.7 million | 3.2 million |
2023-06-30 | -32.6 million | 2.8 million |
2023-03-31 | 174.5 million | 3.0 million |
2022-12-31 | -25.4 million | 3.3 million |
OMER Net Income
No data available :(
OMER Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 310.3 million | - | 24.1 million |
2023-06-30 | 341.3 million | 221.5 million | 25.1 million |
2023-03-31 | 371.4 million | 221.2 million | 25.7 million |
2022-12-31 | 194.9 million | 220.9 million | 26.7 million |
OMER Shares Outstanding
OMER Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 33000 | 31.7 million | 16.4 million | - |
2023-06-30 | 275000 | 29.6 million | 11.3 million | - |
2023-03-31 | 275000 | 24.6 million | 11.1 million | - |
2022-12-31 | 13000 | 26.6 million | 13.6 million | - |
OMER Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 197000 |
2023-06-30 | - | 300000 |
2023-03-31 | - | 186000 |
2022-12-31 | - | 163000 |
OMER
Price: $3.73
52 week price:
Earnings Per Share: -2.89 USD
P/E Ratio: -1.32
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 328300
Ebitda: -4.6 millionMarket Capitalization: 198.0 million